Read + Share
Wang CC, Kao JH. Letter to the Editor Learning more about the safety of atezolizumab plus
bevacizumab in patients with hepatocellular carcinoma. Hepatology 2023 Jan 3. doi: 10.1097/HEP.0000000000000009.
PMID: 36626618
|
 |
|
Wang CC, Kao JH. Letter to the Editor Learning more about the safety of atezolizumab plus
bevacizumab in patients with hepatocellular carcinoma. Hepatology 2023 Jan 3. doi: 10.1097/HEP.0000000000000009.
PMID: 36626618
|
|
|
|